Md. Meraj Ansari – författare

Inflammatory and non-communicable diseases (NCDs) have a significant impact on public health as well as socio-economic conditions across the globe. According to the WHO (World Health Organization), NCDs kill a devastating 41 million humans every year. Sufficient nutrition and good health depend on eating a balanced diet. It guards against a variety of chronic NCDs, including cancer, diabetes and heart disease. A balanced diet must include a range of foods. Advances in science, technology, and the interpretation of food chemistry and biological functions by food researchers have led to a shift in consumers' perceptions of food functions, from satisfaction and nutrition to health. Long-term unhealthy diets cause many human chronic diseases, as epidemiological research demonstrates. Many bioactive food components, such as polyphenols, polysaccharides, flavonoids, peptides and saponins, offer multiple health benefits. Research also demonstrates that food plays a significant role in the majority of acute and chronic human diseases. In order to prevent chronic diseases, improve quality of life, and eventually develop new or enhanced healthy meals, it is crucial to have a deeper understanding of the bioaccessibility, safety concerns and underlying health-promoting mechanisms of food-derived bioactive components. Despite tremendous advancements in therapeutics, the cure of dreadful diseases such as cancer, neurodegenerative disease, colitis and rheumatoid arthritis is still a significant challenge. Furthermore, therapeutic repercussions in terms of side effects and the emergence of multi-drug resistance make therapeutics more complicated. Bioactive Food Ingredients in Managing Inflammatory Diseases illustrates the significance of bioactive food ingredients in tackling inflammation and inflammatory diseases. The potential of food ingredients as anti-oxidative and anti-inflammatory strategies, their mechanistic insight into scavenging free radicals, and their application in managing inflammation and inflammatory diseases. With the focus on challenges and advances in using bioactive food ingredients for enhanced therapeutic efficacy. The text studies the potentiality of bioactive food ingredients in the management of inflammation and inflammatory disease, providing researchers with a valuable single source reference for the very latest in bioactive foods and their use in treating inflammatory diseases.

Inflammatory and non-communicable diseases (NCDs) have a significant impact on public health as well as socio-economic conditions across the globe. According to the WHO (World Health Organization), NCDs kill a devastating 41 million humans every year. Sufficient nutrition and good health depend on eating a balanced diet. It guards against a variety of chronic NCDs, including cancer, diabetes and heart disease. A balanced diet must include a range of foods. Advances in science, technology, and the interpretation of food chemistry and biological functions by food researchers have led to a shift in consumers' perceptions of food functions, from satisfaction and nutrition to health. Long-term unhealthy diets cause many human chronic diseases, as epidemiological research demonstrates. Many bioactive food components, such as polyphenols, polysaccharides, flavonoids, peptides and saponins, offer multiple health benefits. Research also demonstrates that food plays a significant role in the majority of acute and chronic human diseases. In order to prevent chronic diseases, improve quality of life, and eventually develop new or enhanced healthy meals, it is crucial to have a deeper understanding of the bioaccessibility, safety concerns and underlying health-promoting mechanisms of food-derived bioactive components. Despite tremendous advancements in therapeutics, the cure of dreadful diseases such as cancer, neurodegenerative disease, colitis and rheumatoid arthritis is still a significant challenge. Furthermore, therapeutic repercussions in terms of side effects and the emergence of multi-drug resistance make therapeutics more complicated. Bioactive Food Ingredients in Managing Inflammatory Diseases illustrates the significance of bioactive food ingredients in tackling inflammation and inflammatory diseases. The potential of food ingredients as anti-oxidative and anti-inflammatory strategies, their mechanistic insight into scavenging free radicals, and their application in managing inflammation and inflammatory diseases. With the focus on challenges and advances in using bioactive food ingredients for enhanced therapeutic efficacy. The text studies the potentiality of bioactive food ingredients in the management of inflammation and inflammatory disease, providing researchers with a valuable single source reference for the very latest in bioactive foods and their use in treating inflammatory diseases.

This contributed volume offers a comprehensive exploration of the latest advancements in diagnosing and managing autoimmune diseases, with a focus on emerging treatments and disease-specific interventions. It brings together leading experts from around the world to provide a detailed roadmap for addressing these conditions using cutting-edge approaches.The chapters cover diverse topics, including the pathogenesis and management of rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Readers will discover innovations in early diagnosis, targeted drug delivery systems, and the application of nanomaterials in treatment. The book also highlights the role of precision medicine and advanced diagnostic techniques in improving patient outcomes, supported by detailed illustrations and expert analyses.This book is an invaluable resource for graduate and postgraduate students, researchers, and policymakers interested in the latest strategies for autoimmune disease management. Offering a global perspective and multidisciplinary insights, it is a must-read for medical professionals and academics alike.

This contributed volume offers a comprehensive exploration of the latest advancements in diagnosing and managing autoimmune diseases, with a focus on emerging treatments and disease-specific interventions. It brings together leading experts from around the world to provide a detailed roadmap for addressing these conditions using cutting-edge approaches.The chapters cover diverse topics, including the pathogenesis and management of rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Readers will discover innovations in early diagnosis, targeted drug delivery systems, and the application of nanomaterials in treatment. The book also highlights the role of precision medicine and advanced diagnostic techniques in improving patient outcomes, supported by detailed illustrations and expert analyses.This book is an invaluable resource for graduate and postgraduate students, researchers, and policymakers interested in the latest strategies for autoimmune disease management. Offering a global perspective and multidisciplinary insights, it is a must-read for medical professionals and academics alike.

This book presents the latest technology of sustainable nanomaterials for applications as drug delivery cargos in tackling various inflammatory diseases. The chapters in this book describe nanotechnology-based drug delivery strategies, the mechanistic insights of nanoformulations and their application in managing inflammation diseases such as rheumatoid arthritis, ulcerative colitis, cancer and neurological disorder. It looks into the challenges of using nanomaterials-based smart materials for enhanced therapeutic efficacy while maintaining safe and sustainable procedures. The book is divided into three main sections: A) Fundamental of smart nanocarriers and nanoformulations targeted drug delivery in inflammatory disease; B) Smart nano drug delivery therapy- an emerging approach towards inflammatory diseases and C) Novel nano delivery strategies in targeting major inflammatory diseases. The book targets early researchers and clinical practitioners who are interested in the management and treatment of inflammatory diseases using nanotechnology-based drug delivery systems.